|
The documentary 'QSARs in REACH?' is based on interviews with regulators, industry and QSAR developers, and addresses some of the key issues and priorities in the further use of QSARs within REACH. The documentary was first shown at the ORCHESTRA booth at the 2011 SETAC Europe conference in Milan. Here it can be viewed online in 4 short... |
7 reasons to use in-silico methods1. Cost and feasibilityThe REACH legislation requires industry to evaluate the toxicity not just of new chemicals, but also of the tens of thousands of existing chemical substances that are currently in use but have never been subject to regulatory testing. ... |
||
|
|
|
||
|
|
The leaflet is intended as a concise and accessible explanation of in silico methods, and the issues around them, for people who want to know about them, and/or what to understand what the ORCHESTRA project is about.
|
||
|
This page lists various documents published by Orchestra. Please visit also the structured Documents page to find out more
|
Any model, such as animal models (also called in vivo) or cellular models (in vitro models), is a system which applies to a specific situation, and simplifies a complex system, which cannot be used experimentally for investigation. For instance, in case of toxicity studies, the target is human health, and for environmental studies the target may be a certain ecosystem. In... |
 |
Join our network of stakeholders. You can add your details as a potential stakeholder for our actions using this form |
Learn more about in silico, browse resources,
find out what's happening and get involved
Commission of the European Communities through the FP7-COOPERATION contract 226521 - ORCHESTRA
The short questionnaire is our invitation to policy makers, industry managers, educators, political leaders, NGOs, investors, citizens and all others who are not...
Twitter 
Facebook